FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

20251 citationsJournal Articlegreen Open Access

Authors

Matthew J. Maurer · Mayo Clinic in Arizona

Vít Procházka · University Hospital Olomouc

Tarec Christoffer El‐Galaly · Aalborg University Hospital

Christopher R. Flowers · The University of Texas MD Anderson Cancer Center

Diego Villa · University of British Columbia

Emmanuel Bachy · Hôpital Lyon Sud

Elliot Cahn

Abstract

The FLIPI24 model robustly stratifies, at diagnosis, patients with FL at increased risk of lymphoma-related death versus patients with very low lymphoma-related mortality during the first decade after diagnosis. FLIPI24 can be used to enrich future clinical trial designs in newly diagnosed FL.

Topics & Keywords

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research CNS Lymphoma Diagnosis and Treatment

Publication Details

Published in: Journal of Clinical Oncology

Volume 44, Issue 2, pp. 117-128

DOI: 10.1200/jco-25-00892

Field-Weighted Citation Impact: 1.43

Command Palette

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

Authors

Abstract

Topics & Keywords

Publication Details